AIM ImmunoTech(AIM)
$0.14-0.02 (-10.97%)
AIM
AIM ImmunoTech Revenue
$0.14
At close:-0.02 (-10.97%)
Want to see AIM full AI Analyst Report?
AIM ImmunoTech (AIM) Revenue
1,083 Followers
AIM ImmunoTech Revenue
AIM ImmunoTech had a revenue of 26.00K in the quarter ending Jun 30, 2026, with 18.18%. This bring the company's revenue in the last twelve months to 95.00K, Increased 1.06%. In the fiscal year ending Mar 31, 2026, AIM ImmunoTech had annual revenue of 88.00K with -48.24% growth.
- Revenue (ttm)
- 95.00K
- Revenue Growth
- -21.49%
- P/S Ratio
- 62.56
- Revenue/Employee
- $4,632
- Employees
- 19
- Market Cap
- $5.51M
Revenue Chart
AIM ImmunoTech Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 88.00K | -82.00K | -48.24% |
| Dec 31, 2024 | 170.00K | -32.00K | -15.84% |
| Mar 31, 2024 | 202.00K | 61.00K | 43.26% |
| Mar 31, 2023 | 141.00K | 6.00K | 4.44% |
| Mar 31, 2022 | 135.00K | -28.00K | -17.18% |
| Mar 31, 2021 | 163.00K | 23.00K | 16.43% |
| Mar 31, 2020 | 140.00K | -227.00K | -61.85% |
| Mar 31, 2019 | 367.00K | -70.00K | -16.02% |
| Dec 31, 2017 | 437.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.